FAQs

  1. 1 What is the AMARANTH study?

    The AMARANTH Study will evaluate the safety and effectiveness of an investigational drug in people with early Alzheimer’s disease. The aim of the study is to determine whether the investigational drug can slow down the deterioration of the brain in people with early Alzheimer’s disease.

  2. 2 Who sponsors clinical trials?

    Clinical trials are sponsored, or funded, by a variety of organizations or individuals such as physicians, medical institutions, foundations, voluntary groups, and pharmaceutical companies, in addition to federal agencies such as the National Institutes of Health (NIH), the Department of Defense (DOD), and the Department of Veteran’s Affairs (VA). Trials can take place in a variety of locations, such as hospitals, universities, doctors’ offices, or community clinics.

  3. 3 How will I know if I am eligible for this clinical research study?

    If you would like to learn more about this clinical research study, please take the pre-qualification screener. If you pre-qualify for the AMARANTH Study you will be referred to a study center near you. The staff at the study center will discuss the AMARANTH Study with you in more detail. The study doctor at the study center will ask you some medical questions to see if you are suitable to participate in this clinical research study.

  4. 4 Do I need to ask my regular doctor before I can participate in this clinical research study?

    No. However, you should tell your usual doctor that you are thinking of participating in this clinical research study. Your doctor may wish to contact the study doctor (with your permission) to request additional information.

  5. 5 Will I have to switch doctors?

    Most clinical research studies provide study-related treatment for a specific condition and a specific length of time. Clinical research studies do not provide extended or comprehensive health care for any other conditions you may have. Your family doctor may wish to work with the study team to best determine which treatments or medications are most appropriate for your care. At the end of the study, your care will return, in full, to your regular doctor.

  6. 6 How will I be compensated for my participation in this study?

    All investigational study medications and study-related care are provided at no cost to you.

  7. 7 Where are the study centers?

    The study sites are located worldwide.

  8. 8 What is the investigational study medication that is being tested?

    This investigational drug may help reduce the creation of substances that will eventually become amyloid, and it will be tested to see if it slows down the deterioration of the brain in people with early Alzheimer’s disease.

  9. 9 Who will have access to my name and the information collected during participation?

    Your personally identifiable information (for example: name, and address) will not be accessible to anyone who is not directly associated with this clinical research study, except with your permission or as required by law.

    The results of this study (for example, information learned, data that is collected, or conclusions) may be published. However, this information will only be combined with other participants’ data and cannot be used to identify any individual participant.

    The sponsor of this clinical research study will not have access to any personally identifiable information submitted through this website.

Ready to get started?

Find a site